{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:22:43Z","timestamp":1788326563397,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ygyno.2013.09.018","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T21:31:06Z","timestamp":1379712666000},"page":"555-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Secretory cell expansion with aging: Risk for pelvic serous carcinogenesis"],"prefix":"10.1016","volume":"131","author":[{"given":"Jie","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen","family":"Abushahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janiel M.","family":"Cragun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setsuko K.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Hatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beihua","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.09.018_bb0005","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1056\/NEJM199311183292108","article-title":"Cancer of the ovary","volume":"329","author":"Cannistra","year":"1993","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-8722-5-8","article-title":"Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis","volume":"5","author":"Li","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2559.2011.04167.x","article-title":"Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum)","volume":"61","author":"Delair","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0020","first-page":"20","article-title":"Prevention of ovarian cancer: intraepithelial neoplasia","volume":"9","author":"Brewer","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0025","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2011.106","article-title":"Tubal origin of 'ovarian' low-grade serous carcinoma","volume":"24","author":"Li","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/modpathol.2011.175","article-title":"PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer","volume":"25","author":"Quick","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0035","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GCO.0b013e328011a21f","article-title":"The distal fallopian tube: a new model for pelvic serous carcinogenesis","volume":"19","author":"Crum","year":"2007","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0050","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":"Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0065","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2741\/e275","article-title":"STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis","volume":"3","author":"Mehra","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"issue":"Suppl. 1","key":"10.1016\/j.ygyno.2013.09.018_bb0075","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1097\/IGC.0b013e31824d7269","article-title":"BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis","volume":"22","author":"Crum","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00004347-200304000-00001","article-title":"Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations","volume":"22","author":"Colgan","year":"2003","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0085","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/pgp.0b013e31814b191f","article-title":"Serous carcinogenesis in the fallopian tube: a descriptive classification","volume":"27","author":"Jarboe","year":"2008","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":"Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":"The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2006.06.024","article-title":"PAX genes: roles in development, pathophysiology, and cancer","volume":"73","author":"Lang","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0115","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0120","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1210\/en.2006-1054","article-title":"Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy","volume":"148","author":"Mittag","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0125","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/PAS.0b013e31816d71ad","article-title":"Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas","volume":"32","author":"Nonaka","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/dc.21426","article-title":"Pax8: a marker for carcinoma of Mullerian origin in serous effusions","volume":"39","author":"Tong","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0140","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/GRF.0b013e31824b1725","article-title":"The oviduct and ovarian cancer: causality, clinical implications, and \"targeted prevention\"","volume":"55","author":"Crum","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0150","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0155","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/GRF.0b013e31824b4611","article-title":"Ovarian cancer: etiology, risk factors, and epidemiology","volume":"55","author":"Hunn","year":"2012","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0165","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/modpathol.2009.64","article-title":"Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria","volume":"22","author":"Semmel","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.12046","article-title":"Fallopian tube precursors of ovarian low- and high-grade serous neoplasms","volume":"62","author":"Vang","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0175","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/PGP.0b013e31822ea955","article-title":"Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases","volume":"31","author":"Tang","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.ygyno.2013.09.018_bb0180","first-page":"433","article-title":"Morphologic changes of fallopian tubal epithelium in ovarian serous tumors","volume":"41","author":"Wen","year":"2012","journal-title":"Zhonghua Bing Li Xue Za Zhi"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,4]],"date-time":"2020-08-04T13:39:43Z","timestamp":1596548383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581301192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S009082581301192X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.09.018","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secretory cell expansion with aging: Risk for pelvic serous carcinogenesis","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}